Hyro vs Infermedica
Both stand between a patient with a problem and the health system, and only one of them is regulated for it. Infermedica runs clinical triage, guiding a patient from an undifferentiated symptom to a level of care through a dynamic question flow over a physician curated knowledge base, and it is certified as a Class IIb medical device in Europe. Hyro is a conversational platform built for healthcare from inception, covering call centres, websites, text and mobile, which reaches far more of the actual call volume because most of it never needed triage. The line between them is the one a buyer must not blur: answering a question about parking is not the same product as telling someone whether to go to an emergency department, and the second carries a device obligation the first does not. Deploy Hyro for volume, Infermedica where urgency is being judged.
- It is certified as a Class IIb medical device in Europe and registered with the relevant regulator, which is a materially higher regulatory bar than anything else in this lane clears.
- Three routes to inspection exist where most vendors offer none, including a published architecture description over a physician curated knowledge base covering around a thousand conditions.
- The strongest published security posture assessed here in some time, earned through external certification rather than asserted, and built interface first so it sits inside other organisations' products.
- It handles the whole conversation rather than the triage question, spanning call centres, websites, text and mobile applications, and it was built for healthcare from inception rather than adapted to it.
- Conversational coverage means one platform answers the routine questions that never needed triage at all, which is where most of the call volume actually sits.
- For a health system whose problem is call handling capacity rather than clinical routing, a conversational platform reaches more of the volume than a triage engine does.
Side by Side
| Axis | H Hyro |
I Infermedica |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
The regulatory asymmetry here is the most important fact and it is easy to miss: a product that tells a patient what level of care to seek is regulated as a medical device in Europe and Infermedica holds that certification, while conversational platforms that route or answer are generally outside the device framework. If a deployment has an agent making any statement about urgency, establish which side of that line the vendor sits on and under whose reading.
Neither vendor publishes accuracy evidence for triage outcomes or a bias evaluation, and triage engines are known to generalise unevenly across populations whose symptom descriptions differ from the training corpus. Neither publishes pricing.